Palisade Bio, Inc. (PALI)

Palisade Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	133.39	9.82	12.43	12.38	10.5
Cash & Short-Term Investments	133.39	9.82	12.43	12.38	10.5
Cash Growth	1258.16%	-21.00%	0.40%	17.99%	1371.95%
Other Current Assets	0.84	0.67	0.9	2.35	1.01
Total Current Assets	134.22	10.49	13.33	14.73	11.51
Net Property, Plant & Equipment	-	0.09	0.21	0.31	0.11
Other Long-Term Assets	0.12	0.3	0.52	0.72	0.89
Total Assets	134.34	10.88	14.05	15.76	12.51
Accounts Payable	0.77	1.11	0.7	1.76	1.32
Accrued Expenses	3.49	1.96	1.61	1.06	0.97
Short-Term Debt	0.07	0.08	0.16	0.09	-
Current Portion of Long-Term Debt	-	-	-	-	0.09
Current Portion of Leases	-	0.09	0.12	0.11	0.11
Other Current Liabilities	0.31	-	-	-	-
Total Current Liabilities	4.64	3.24	2.59	3.01	2.5
Long-Term Leases	-	-	0.09	0.21	-
Other Long-Term Liabilities	0.33	0.15	0.06	0.06	2.65
Total Long-Term Liabilities	0.33	0.15	0.15	0.27	2.65
Total Liabilities	4.96	3.39	2.74	3.28	5.15
Preferred Stock	0	0	0	0	0
Common Stock	1.59	0.03	0.01	0.03	0
Additional Paid-in Capital	280.51	143.41	132.81	121.64	102
Retained Earnings	-152.73	-135.94	-121.51	-109.19	-94.64
Total Common Shareholders' Equity	129.38	7.49	11.31	12.48	7.37
Shareholders' Equity	129.38	7.49	11.31	12.48	7.37
Total Liabilities & Equity	134.34	10.88	14.05	15.76	12.51
Total Debt	0.07	0.17	0.37	0.4	0.2
Net Cash (Debt)	133.31	9.65	12.06	11.98	10.3
Net Cash Growth	1281.21%	-19.99%	0.70%	16.35%	-
Net Cash Per Share	2.40	6.81	12.21	204.12	826.07
Book Value	129.38	7.49	11.31	12.48	7.37
Book Value Per Share	2.32	5.29	11.45	212.64	590.91
Tangible Book Value	129.38	7.49	11.31	12.48	7.37
Tangible Book Value Per Share	2.32	5.29	11.45	212.64	590.91

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q